Bridgeway Capital Management’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-120,300
| Closed | -$84K | – | 1482 |
|
|
2023
Q1 | $84K | Buy |
120,300
+50,000
| +71% | +$34.9K | ﹤0.01% | 1263 |
|
|
2022
Q4 | $63.3K | Sell |
70,300
-45,000
| -39% | -$40.5K | ﹤0.01% | 1276 |
|
|
2022
Q3 | $692K | Sell |
115,300
-12,000
| -9% | -$72K | 0.02% | 816 |
|
|
2022
Q2 | $527K | Buy |
127,300
+10,000
| +9% | +$41.4K | 0.01% | 865 |
|
|
2022
Q1 | $446K | Buy |
117,300
+12,000
| +11% | +$45.6K | 0.01% | 969 |
|
|
2021
Q4 | $474K | Sell |
105,300
-30,000
| -22% | -$135K | 0.01% | 993 |
|
|
2021
Q3 | $630K | Buy |
135,300
+110,300
| +441% | +$514K | 0.01% | 969 |
|
|
2021
Q2 | $176K | Hold |
25,000
| – | – | ﹤0.01% | 1275 |
|
|
2021
Q1 | $148K | Hold |
25,000
| – | – | ﹤0.01% | 1304 |
|
|
2020
Q4 | $115K | Buy |
+25,000
| New | +$115K | ﹤0.01% | 1259 |
|